当前位置: X-MOL 学术J. Clin. Invest. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
The atypical antipsychotic olanzapine causes weight gain by targeting serotonin receptor 2C
The Journal of Clinical Investigation ( IF 13.3 ) Pub Date : 2017-08-14 , DOI: 10.1172/jci93362
Caleb C. Lord , Steven C. Wyler , Rong Wan , Carlos M. Castorena , Newaz Ahmed , Dias Mathew , Syann Lee , Chen Liu , Joel K. Elmquist

Atypical antipsychotics such as olanzapine often induce excessive weight gain and type 2 diabetes. However, the mechanisms underlying these drug-induced metabolic perturbations remain poorly understood. Here, we used an experimental model that reproduces olanzapine-induced hyperphagia and obesity in female C57BL/6 mice. We found that olanzapine treatment acutely increased food intake, impaired glucose tolerance, and altered physical activity and energy expenditure in mice. Furthermore, olanzapine-induced hyperphagia and weight gain were blunted in mice lacking the serotonin 2C receptor (HTR2C). Finally, we showed that treatment with the HTR2C-specific agonist lorcaserin suppressed olanzapine-induced hyperphagia and weight gain. Lorcaserin treatment also improved glucose tolerance in olanzapine-fed mice. Collectively, our studies suggest that olanzapine exerts some of its untoward metabolic effects via antagonism of HTR2C.

中文翻译:

非典型抗精神病药物奥氮平通过靶向血清素2C引起体重增加

非典型抗精神病药(例如奥氮平)通常会导致体重增加过多和2型糖尿病。但是,这些药物引起的代谢扰动的机制仍知之甚少。在这里,我们使用了在雌性C57BL / 6小鼠中重现奥氮平诱导的食欲亢进和肥胖症的实验模型。我们发现奥氮平治疗可急剧增加食物摄入量,损害葡萄糖耐量,并改变小鼠的体育活动和能量消耗。此外,在缺乏血清素2C受体(HTR2C)的小鼠中,奥氮平诱发的食欲亢进和体重增加减弱。最后,我们证明了用HTR2C特异性激动剂lorcaserin治疗可抑制olanzapine所引起的食欲亢进和体重增加。Lorcaserin治疗还改善了奥氮平喂养小鼠的葡萄糖耐量。总的来说,
更新日期:2017-09-08
down
wechat
bug